Patents by Inventor Christopher A. Lowry

Christopher A. Lowry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
    Patent number: 11904007
    Abstract: Methods of treating or preventing stress, anxiety, or postoperative cognitive dysfunction. Also provided are methods of improving resilience in a subject by administering a therapeutically effective amount of isolated mycobacterium.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: February 20, 2024
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Christopher A. Lowry, Matthew G. Frank, Laura Fonken, Steven F. Maier
  • Protection from Stress, Anxiety, Neuroinflammation, and Cognitive Dysfunction
    Publication number: 20220409714
    Abstract: Methods of treating or preventing stress, anxiety, or postoperative cognitive dysfunction. Also provided are methods of improving resilience in a subject by administering a therapeutically effective amount of isolated mycobacterium.
    Type: Application
    Filed: August 22, 2022
    Publication date: December 29, 2022
    Inventors: Christopher A. Lowry, Matthew G. Frank, Laura Fonken, Steven F. Maier
  • Compositions and methods for treating or ameliorating cocaine addiction
    Patent number: 11471496
    Abstract: The present invention provides compositions and methods for treating, ameliorating, and/or preventing cocaine addiction in a subject. Immunization by M. vaccae alters serotonin signaling in the brain, reducing stress- and anxiety-like responding in animal models of post-traumatic stress disorder and other anxiety disorders. In certain embodiments, the immunoregulatory, anti-stress, and anxiolytic effects of M. vaccae immunization reduces addiction- and relapse-like responding in models of cocaine addiction and alter the development of cocaine-induced neuroinflammation.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: October 18, 2022
    Assignees: Rowan University, The Regents of the University of Colorado
    Inventors: Thomas M. Keck, Christopher A. Lowry
  • Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
    Patent number: 11433126
    Abstract: Methods of treating or preventing stress, anxiety, or postoperative cognitive dysfunction. Also provided are methods of improving resilience in a subject by administering a therapeutically effective amount of isolated Mycobacterium.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: September 6, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Christopher A. Lowry, Matthew G. Frank, Laura Fonken, Steven F. Maier
  • Protection from Stress, Anxiety, Neuroinflammation, and Cognitive Dysfunction
    Publication number: 20210275659
    Abstract: Methods of treating or preventing stress, anxiety, or postoperative cognitive dysfunction. Also provided are methods of improving resilience in a subject by administering a therapeutically effective amount of isolated Mycobacterium.
    Type: Application
    Filed: December 17, 2020
    Publication date: September 9, 2021
    Inventors: Christopher A. Lowry, Matthew G. Frank, Laura Fonken, Steven F. Maier
  • IMMUNOTHERAPEUTIC AGENT
    Publication number: 20200297680
    Abstract: Compounds for use in the treatment of sepsis and/or the prevention or treatment of post-sepsis syndrome.
    Type: Application
    Filed: March 31, 2020
    Publication date: September 24, 2020
    Inventors: Laura Rosa Brunet, Christopher A. Lowry
  • COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING COCAINE ADDICTION
    Publication number: 20200276248
    Abstract: The present invention provides compositions and methods for treating, ameliorating, and/or preventing cocaine addiction in a subject. Immunization by M. vaccae alters serotonin signaling in the brain, reducing stress- and anxiety-like responding in animal models of post-traumatic stress disorder and other anxiety disorders. In certain embodiments, the immunoregulatory, anti-stress, and anxiolytic effects of M. vaccae immunization reduces addiction- and relapse-like responding in models of cocaine addiction and alter the development of cocaine-induced neuroinflammation.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 3, 2020
    Inventors: THOMAS M. KECK, CHRISTOPHER A. LOWRY
  • Immunotherapeutic agent
    Patent number: 10736864
    Abstract: Compounds for use in the treatment of sepsis and/or the prevention or treatment of post-sepsis syndrome.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: August 11, 2020
    Assignees: IMMODULON THERAPEUTICS LIMITED, THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Laura Rosa Brunet, Christopher A. Lowry
  • IMMUNOTHERAPEUTIC AGENT
    Publication number: 20190167623
    Abstract: Compounds for use in the treatment of sepsis and/or the prevention or treatment of post-sepsis syndrome.
    Type: Application
    Filed: February 7, 2019
    Publication date: June 6, 2019
    Inventors: Laura Rosa Brunet, Christopher A. Lowry
  • IMMUNOTHERAPEUTIC AGENT
    Publication number: 20180185317
    Abstract: Compounds for use in the treatment of sepsis and/or the prevention or treatment of post-sepsis syndrome.
    Type: Application
    Filed: December 28, 2017
    Publication date: July 5, 2018
    Inventors: Laura Rosa Brunet, Christopher A. Lowry